本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ImmunityBio, Inc.

2.72
+0.08003.03%
盘后2.70-0.0200-0.74%16:38 EDT
成交量:327.53万
成交额:883.18万
市值:24.01亿
市盈率:-4.73
高:2.75
开:2.71
低:2.65
收:2.64
数据加载中...
2021/03/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/10

重要事件披露

8-K - Current report
2021/03/08

企业合并公告

425 - Prospectuses and communications, business combinations
2021/03/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

企业合并公告

425 - Prospectuses and communications, business combinations
2021/02/25

企业合并公告

425 - Prospectuses and communications, business combinations
2021/02/25

重要事件披露

8-K - Current report
2021/02/25

企业合并公告

425 - Prospectuses and communications, business combinations
2021/02/24

重要事件披露

8-K - Current report
2021/02/24

企业合并公告

425 - Prospectuses and communications, business combinations
2021/02/10

重要事件披露

8-K - Current report
2021/01/13

重要事件披露

8-K - Current report
2021/01/13

企业合并公告

425 - Prospectuses and communications, business combinations
2020/12/22

重要事件披露

8-K - Current report
2020/12/22

企业合并公告

425 - Prospectuses and communications, business combinations
2020/12/22

企业合并公告

425 - Prospectuses and communications, business combinations
2020/12/21

重要事件披露

8-K - Current report
2020/12/21

企业合并公告

425 - Prospectuses and communications, business combinations
2020/12/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/21

企业合并公告

425 - Prospectuses and communications, business combinations